pnv
PNV: Medical Device Pioneer - Healing Promise Meets Reality Check
Updated 8 Oct 2025
Medical device manufacturer with 54% revenue growth but trading at 237x EBITDA. Fair value A$1.06 vs current A$1.48 implies 28% downside risk.
View noteMedical device manufacturer with 54% revenue growth but trading at 237x EBITDA. Fair value A$1.06 vs current A$1.48 implies 28% downside risk.
View note